MedTrace Logo

Screening for Silent Atrial Fibrillation During Influenza Vaccination

NCT02006524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3269

Last updated 2016-05-12

No results posted yet for this study

Summary

Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).

Conditions

Interventions

DEVICE

'MyDiagnostick

Sponsors & Collaborators

Principal Investigators

  • Robert Tieleman, MD PhD · Martini Ziekenhuis Groningen

  • Monika Hollander, MD PhD · Julius Center UMC Utrecht

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02006524 on ClinicalTrials.gov